Microglia/neuron crosstalk in autism spectrum disorder: Role of early inflammatory activation (MINERVA)

Description of the granted funding

The goal of MINERVA is to understand how the immune system and genetic risk factors influence the activity of immune cells in the brain, the microglia, and their communication with neurons, and how these processes modulate neurodevelopmental alterations and the severity of autism spectrum disorder (ASD). The results of these studies will help to better understand the mechanisms of the immune system that are associated with ASD development and behavioral impairment. In addition, based on these results, innovative therapeutic approaches may be developed that target neuroimmune and behavioral deficits in ASD.
Show more

Starting year

2022

End year

2024

Granted funding

Tarja Malm Orcid -palvelun logo
299 439 €

Funder

Research Council of Finland

Funding instrument

International joint call

Other information

Funding decision number

351968

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience